The outbreak of COVID-19 is not set to increase growth in 2020, with value growth of 3% predicted, compared to value growth of 4% recorded in 2019. Unlike other countries within Western Europe, there was not a high level of stockpiling reported for consumer health products in Norway. However, adult acetaminophen was one area which recorded a spike in sales in Q1 and Q2, due to the negative press surrounding ibuprofen, and adverse effects the product could have on those suffering from COVID-19. T...

ALSO READ:  http://www.marketwatch.com/story/global-home-smart-thermostat-marke...

Euromonitor International's Consumer Health in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2015-2019, allowing you to identify the sectors driving growth. Forecasts to 2024 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

ALSO READ:  http://www.marketwatch.com/story/global-protective-helmet-market-si...

Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

ALSO READ:  http://www.marketwatch.com/story/global-wet-tissues-and-wipes-marke...

Table of Contents

Consumer Health in Norway
Euromonitor International
November 2020

List OF CONTENTS AND TABLES

EXECUTIVE SUMMARY
COVID-19 impact on consumer health
COVID-19 country impact
Company response
Retailing shift
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2015-2020
Table 2 Life Expectancy at Birth 2015-2020
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2015-2020
Table 4 Sales of Consumer Health by Category: % Value Growth 2015-2020
Table 5 NBO Company Shares of Consumer Health: % Value 2016-2020
Table 6 LBN Brand Shares of Consumer Health: % Value 2017-2020
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2015-2020
Table 8 Distribution of Consumer Health by Format: % Value 2015-2020
Table 9 Distribution of Consumer Health by Format and Category: % Value 2020
Table 10 Forecast Sales of Consumer Health by Category: Value 2020-2025
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2020-2025
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2019-2020
GLOBAL MACROECONOMIC ENVIRONMENT
GLOBAL INDUSTRY ENVIRONMENT
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources

ALSO READ:  http://www.marketwatch.com/story/global-pigmented-lesion-treatment-...

KEY DATA FINDINGS
2020 IMPACT
Sales of ibuprofen decline as stories suggest the drug has adverse effects on those suffering from COVID-19, causing high levels of growth for acetaminophen
Diclofenac switches from OTC to Rx status, further boosting sales of adult acetaminophen in 2020
Paracet set to record double-digit growth, maintaining Karo Pharma AS leading position
RECOVERY AND OPPORTUNITIES
The forecast period will record a solid performance, as topical analgesics/anaesthetic and ibuprofen drive value growth
The outbreak of COVID-19, increases the interest in health, boosting sales for topical analgesics/anaesthetic
Prescription analgesics and a lack of innovation on the landscape are both threats to growth across the forecast period

ALSO READ:  http://www.marketwatch.com/story/global-ash-fusion-testers-market-s...

CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2015-2020
Table 13 Sales of Analgesics by Category: % Value Growth 2015-2020
Table 14 NBO Company Shares of Analgesics: % Value 2016-2020
Table 15 LBN Brand Shares of Analgesics: % Value 2017-2020
Table 16 Forecast Sales of Analgesics by Category: Value 2020-2025
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2020-2025
KEY DATA FINDINGS
2020 IMPACT
Cough remedies and nasal sprays drive growth, as demand is driven up by the outbreak of COVID-19
Rising incidence of allergies leads to positive value growth for antihistamines/allergy remedies (systemic)
Otrivin from GlaxoSmithKline AS records an increase in sales, as nasal sprays sell-out in some stores, due to the outbreak of COVID-19

….CONTINUED

CONTACT DETAILS :

[email protected]

+44 203 500 2763

+1 62 825 80070

971 0503084105